Gilead Sciences Inc - Company & Market Research Reports

Home /
Companies /
Gilead Sciences Inc

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 172
Infectious Diseases Drugs 134
Genomics 106
Liver and Kidney Disorders Drugs 72
Drug Discovery 64
Immune Disorders Drugs 61
Pharmaceuticals 52
Cardiovascular Drugs 50
Biopharmaceuticals 46
Biotechnology 41
Leukemia Drugs 38
HIV/AIDS Drugs 36
Clinical Trials 33
Lymphoma Drugs 30
Respiratory Drugs 29
Musculoskeletal Disorders Drugs 29
Allergy and Immunology 28
Enzymes 26
Pulmonary Medicine 24
Oncology 22
Central Nervous System Drugs 19
Infusions and Injectables 19
Drug Delivery 19
Pharmaceutical Manufacturing 18
Infectious Disease Testing 14
Vaccines 14
Gastrointestinal Drugs 13
Hematological Drugs 12
Diagnostics 11
Endocrine and Metabolic Disorders Drugs 11
Hematology 10
Sexual and Reproductive Health Drugs 10
Therapeutic Area 9
Healthcare Services 9
Antibiotics 9
Pharmaceutical Intermediates 8
Optical Disorders Drugs 8
Stem Cells 8
Women's Health 7
Breast Cancer Drugs 7
Hepatology 6
Company Reports 5
Lung Cancer Drugs 5
Colon Cancer Drugs 5
Analgesics 5
Needles and Syringes 5
Nanomedicine 5
Liver Cancer Drugs 4
Cervical Cancer Drugs 4
Bladder Cancer Drugs 4
Anesthetic Drugs 4
Biomarkers 4
Dermatology 4
Skin Cancer Drugs 4
Dermatological Drugs 4
Immunosuppressive Drugs 4
Addiction Disorders Drugs 3
Drugs by Therapeutic Area 3
Generic Drugs 3
Prostate Cancer Drugs 3
Ovarian Cancer Drugs 3
Dental 3
Optical 3
Over the Counter (OTC) Drugs 3
Mental Disorders Drugs 3
Biosimilars and Biosuperiors 3
Kidney Cancer Drugs 3
Pediatrics 3
E-Healthcare 2
Pharmacoeconomics 2
Brain Cancer Drugs 2
Proteomics 2
Cardiovascular Devices 2
In Vitro Diagnostics 2
Blood Banking 2
Medical Devices 2
Cancer Vaccines 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Gastroenterology 2
Cardiology 2
Urological Disorders Drugs 2
Animal Pharmaceuticals 1
Neurology 1
Urology and Nephrology 1
Fertility Services 1
Home Testing and Home Healthcare 1
Healthcare 1
Managed Care 1
Transdermal and Transmucosal Drug Delivery 1
Inhalers and Nebulisers 1
Hospital Management 1
Surgical Procedures 1
Molecular Diagnostics 1
Pancreatic Cancer Drugs 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Anatomy 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Asthma Drugs 1
Bronchitis Drugs 1
Schizophrenia Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



278 reviews

1,070 Results (Page 34 of 54)
- Relevance
  Sort by

Inflammatory Bowel Disease Treatment Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3942EUR$4,490USD£3,429GBP

Catecholamines - Global Strategic Business Report

 Report
September 2025
372 Pages
Global

From

€5136EUR$5,850USD£4,467GBP

Neuralgia Treatment - Global Strategic Business Report

 Report
September 2025
276 Pages
Global

From

€5136EUR$5,850USD£4,467GBP

Specialty Pharmaceuticals Market 2025-2029

 Report
August 2025
229 Pages
Global

From

€2195EUR$2,500USD£1,909GBP

Pulmonary Arterial Hypertension (PAH) Drugs Market 2024-2028

 Report
July 2024
180 Pages
Global

From

€2195EUR$2,500USD£1,909GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Lymphoma Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
August 2023
96 Pages
Global

From

€3500EUR$4,271USD£3,151GBP

Leber Congenital Amaurosis - Global Strategic Business Report

 Report
September 2025
402 Pages
Global

From

€5136EUR$5,850USD£4,467GBP

Non-Alcoholic Steatohepatitis Biomarkers Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3942EUR$4,490USD£3,429GBP

Sickle Cell Treatment Market - Global Forecast to 2030

 Report
August 2025
185 Pages
Global

From

€3112EUR$3,545USD£2,707GBP

€3458EUR$3,939USD£3,008GBP

Hospital Infection Therapeutics Market 2025-2029

 Report
May 2025
231 Pages
Global

From

€2195EUR$2,500USD£1,909GBP

Hematological Malignancies Market - Global Forecast 2025-2030

 Report
August 2025
184 Pages
Global

From

€3112EUR$3,545USD£2,707GBP

€3458EUR$3,939USD£3,008GBP

Hepatitis B Vaccine Market Forecasts from 2023 to 2028

 Report
November 2023
146 Pages
Global

From

€3125EUR$3,560USD£2,719GBP

€3907EUR$4,450USD£3,398GBP

Sickle Cell Disease- Pipeline Insight, 2025

 Clinical Trials
April 2025
180 Pages
Global

From

€2195EUR$2,500USD£1,909GBP

Tendonitis Treatment Drug Market - Global Forecast to 2030

 Report
August 2025
186 Pages
Global

From

€3112EUR$3,545USD£2,707GBP

€3458EUR$3,939USD£3,008GBP

Severe Acute Respiratory-Syndrome Treatment Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3942EUR$4,490USD£3,429GBP

Reversible Airway Diseases Treatment Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3942EUR$4,490USD£3,429GBP

Tracheitis Treatment Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3942EUR$4,490USD£3,429GBP

Gastrointestinal Diseases Therapeutics Market - Global Forecast 2025-2030

 Report
August 2025
194 Pages
Global

From

€3112EUR$3,545USD£2,707GBP

€3458EUR$3,939USD£3,008GBP

Small Molecules Drugs for Inflammatory Bowel Diseases Market - Global Forecast 2025-2030

 Report
August 2025
197 Pages
Global

From

€3112EUR$3,545USD£2,707GBP

€3458EUR$3,939USD£3,008GBP

DNA Repair Drugs - Global Strategic Business Report

 Report
September 2025
217 Pages
Global

From

€5136EUR$5,850USD£4,467GBP

1,070 Results (Page 34 of 54)
- 1
- 32
- 33
- 34
- 35
- 36

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.